643 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The Company may, in some cases, use terms
8-K
EX-2.1
zi9btgylxw
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
72tx7jrt 7vqklmf9a8w
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
1e1 lqukumlaxmnao9
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
702kuh7fo4ahg
31 Jan 24
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
8:00am
8-K
EX-10.1
ag70x3ff2bmqei8u
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-1.1
slprkmml zwk91j8x
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
8-K
EX-99.1
m37nyh2yfxdrrwfk6fe3
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
xjs27n8kedvs
9 Nov 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
aaut xtatutu5fw
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm
8-K
EX-99.1
yjwi1q0mvxzk5 jeu40e
15 May 23
Windtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates
4:24pm